NO2296686T3 - - Google Patents

Info

Publication number
NO2296686T3
NO2296686T3 NO09751584A NO09751584A NO2296686T3 NO 2296686 T3 NO2296686 T3 NO 2296686T3 NO 09751584 A NO09751584 A NO 09751584A NO 09751584 A NO09751584 A NO 09751584A NO 2296686 T3 NO2296686 T3 NO 2296686T3
Authority
NO
Norway
Application number
NO09751584A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41100519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2296686(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2296686T3 publication Critical patent/NO2296686T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO09751584A 2008-05-21 2009-05-21 NO2296686T3 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5512008P 2008-05-21 2008-05-21
PCT/US2009/044860 WO2009143356A1 (en) 2008-05-21 2009-05-21 Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia

Publications (1)

Publication Number Publication Date
NO2296686T3 true NO2296686T3 (zh) 2014-07-12

Family

ID=41100519

Family Applications (3)

Application Number Title Priority Date Filing Date
NO09751584A NO2296686T3 (zh) 2008-05-21 2009-05-21
NO16165875A NO3085381T3 (zh) 2008-05-21 2009-05-21
NO2019021C NO2019021I1 (no) 2008-05-21 2019-04-30 Desmopressin eller et acetatsalt derav

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO16165875A NO3085381T3 (zh) 2008-05-21 2009-05-21
NO2019021C NO2019021I1 (no) 2008-05-21 2019-04-30 Desmopressin eller et acetatsalt derav

Country Status (16)

Country Link
US (2) US9974826B2 (zh)
EP (5) EP2712622B1 (zh)
JP (5) JP5767103B2 (zh)
CA (1) CA2724653A1 (zh)
DK (5) DK3225250T3 (zh)
ES (5) ES2710454T3 (zh)
HR (4) HRP20161066T1 (zh)
HU (5) HUE039013T4 (zh)
LT (5) LT2712622T (zh)
LU (1) LUC00015I2 (zh)
NO (3) NO2296686T3 (zh)
PL (5) PL2296686T5 (zh)
PT (5) PT2712622T (zh)
SI (4) SI3225249T1 (zh)
TR (2) TR201807224T4 (zh)
WO (1) WO2009143356A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) * 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
NO2296686T3 (zh) * 2008-05-21 2014-07-12
WO2015063602A1 (en) * 2013-10-29 2015-05-07 Ferring B.V. Desmopressin and blood glucose
CN112912070A (zh) * 2018-10-17 2021-06-04 日本化学药品株式会社 夜间多尿的治疗或预防剂
MX2022012735A (es) * 2020-04-14 2022-11-07 Nippon Chemiphar Co Agente para mejorar la calidad del sueño.
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4285858A (en) * 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) * 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
EP0084705B1 (en) 1981-12-11 1987-01-14 JOHN WYETH & BROTHER LIMITED Process for preparing solid shaped articles
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4878892A (en) 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
DK365389D0 (da) 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
TW279133B (zh) 1990-12-13 1996-06-21 Elan Med Tech
US5527288A (en) * 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9101022D0 (sv) * 1991-01-09 1991-04-08 Paal Svedman Medicinsk suganordning
US6746678B1 (en) * 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
CA2070061C (en) 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
ES2153362T3 (es) 1991-08-26 2001-03-01 Abbott Lab Composiciones y procedimientos de administracion sublingual o bucal de agentes terapeuticos.
AU666509B2 (en) 1991-12-24 1996-02-15 Yamanouchi Pharmaceutical Co., Ltd. Intrabuccally disintegrating preparation and production thereof
US5298256A (en) * 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5534496A (en) * 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
CA2090738C (en) 1993-02-24 1996-05-21 Hema-Quebec Use of paf
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5434121A (en) * 1993-03-25 1995-07-18 Mitsui Toatsu Chemicals, Incorporated Variety of Drechslera monoceras, weed control compositions containing the same as an effective ingredient and weed control methods using the same
SE501677C2 (sv) 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
EP0708657B1 (en) 1993-06-29 2001-07-25 Ferring B.V. Compositions for nasal administration of desmopressin
DE69424940T2 (de) 1993-06-29 2000-12-28 Ferring Bv Synthese zyklischer peptide
US5985835A (en) 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5674850A (en) 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
WO1995014037A1 (en) * 1993-11-17 1995-05-26 Ibah, Inc. Transparent liquid for encapsulated drug delivery
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
FR2720003B1 (fr) * 1994-05-23 1998-06-26 Samsung Electro Mech Dispositif servant à inciser la peau pour une médication transcutanée.
DE4424800A1 (de) * 1994-07-14 1996-01-18 Philips Patentverwaltung Schaltungsanordnung zum Liefern von Speisespannungen
SE518619C2 (sv) * 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
IL113459A (en) * 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US5843016A (en) 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
ATE234129T1 (de) * 1996-06-18 2003-03-15 Alza Corp Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
FR2758195B1 (fr) 1997-01-09 1999-02-26 Sgs Thomson Microelectronics Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele
US5821230A (en) 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6511974B1 (en) * 1997-07-30 2003-01-28 Wyeth Tricyclic vasopressin agonists
US5932745A (en) * 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
US6194407B1 (en) * 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US7138393B2 (en) * 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US6090803A (en) * 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
GB9827292D0 (en) 1998-12-12 1999-02-03 Univ Strathclyde Freeze drying
US6406455B1 (en) 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6620807B1 (en) 1999-02-04 2003-09-16 Wyeth Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
US6235900B1 (en) * 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6344451B1 (en) * 1999-02-04 2002-02-05 American Home Products Pyrrolobenzodiazepine carboxyamide vasopressin agonists
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
TWI271198B (en) 1999-02-15 2007-01-21 Dainippon Sumitomo Pharma Co Tables disintegrating rapidly in the oral cavity
CA2362814A1 (en) 1999-02-18 2000-08-24 Biovalve Technologies, Inc. Electroactive pore
AR014640A1 (es) * 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
US6558695B2 (en) * 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
ATE501751T1 (de) 2000-01-07 2011-04-15 Valeritas Inc Injektionsvorrichtung
US20070032410A1 (en) * 2000-01-11 2007-02-08 Atossa Healthcare, Inc. Compositions and methods for the treatment of psychiatric disorders
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
US6348486B1 (en) * 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
AU2001297823B2 (en) 2000-10-26 2005-05-12 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
EP1339442A4 (en) 2000-11-30 2006-12-27 Biovalve Technologies Inc INJECTION SYSTEMS
ES2705729T3 (es) 2000-11-30 2019-03-26 Valeritas Inc Sistemas de suministro y medición de fluidos
EP1345646A2 (en) * 2000-12-14 2003-09-24 Georgia Tech Research Corporation Microneedle devices and production thereof
AU2002231207A1 (en) * 2000-12-21 2002-07-01 Biovalve Technologies, Inc. Microneedle array systems
JP5354763B2 (ja) 2001-03-16 2013-11-27 アルザ・コーポレーシヨン フェンタニルを投与するための経皮的張り付け剤
JP2004526771A (ja) * 2001-04-12 2004-09-02 ワイス シクロヘキシルフェニルバソプレッシンアゴニスト
US7022699B2 (en) * 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US6903091B2 (en) * 2001-04-12 2005-06-07 Wyeth Biphenyl vasopressin agonists
GB2391480B (en) * 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
US7615234B2 (en) * 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
ATE411276T1 (de) 2001-09-13 2008-10-15 Kissei Pharmaceutical Kristalle eines hydroxynorephedrinderivats
US6723077B2 (en) * 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
US6893655B2 (en) * 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
EP1445253B1 (en) * 2001-11-16 2009-08-05 Astellas Pharma Inc. 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof
PT1501534E (pt) 2002-05-07 2006-09-29 Ferring Bv Formulacoes farmaceuticas
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
CA2516547A1 (en) * 2002-09-30 2004-04-15 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors
WO2004033457A1 (ja) * 2002-10-09 2004-04-22 Toray Industries, Inc. 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体
US7383084B2 (en) * 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
DE10259934B3 (de) * 2002-12-20 2004-10-14 H.C. Starck Gmbh Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
BRPI0409718A (pt) * 2003-04-28 2006-05-02 Astellas Pharma Inc derivado de 4,4-difluoro-1,2,3,4-tetraidro-5h-1-benzazepina ou seu sal
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
KR20060029162A (ko) 2003-06-30 2006-04-04 알자 코포레이션 피부 피어싱 미세돌출부를 코팅하는 방법
CN1826099B (zh) 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
DK1500390T3 (da) * 2003-07-25 2005-09-19 Ferring Bv Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
US6930932B2 (en) * 2003-08-27 2005-08-16 Hewlett-Packard Development Company, L.P. Data signal reception latch control using clock aligned relative to strobe signal
KR20060108682A (ko) * 2003-10-24 2006-10-18 알자 코포레이션 경피 약물 전달을 증대시키기 위한 전처리 방법 및 장치
WO2005041871A2 (en) 2003-10-24 2005-05-12 Alza Corporation Apparatus and method for enhancing transdermal drug delivery
US7097631B2 (en) * 2003-10-31 2006-08-29 Alza Corporation Self-actuating applicator for microprojection array
EP1689419A4 (en) † 2003-11-10 2009-01-14 Reprise Biopharmaceutics Llc PHARMACEUTICAL COMPOSITIONS WITH LOW DOSES OF DESMOPRESSIN
DK1530967T3 (da) 2003-11-13 2006-07-03 Ferring Bv Blisterpakning og dertil hörende fast dosisform
DK1550439T3 (da) 2003-12-29 2006-04-03 Ferring Bv Fremgangsmåde til fremstilling af faste dosisformer af desmopressin
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
KR20060134050A (ko) * 2004-01-09 2006-12-27 알자 코포레이션 주파수 보조 경피성 약제 전달 방법 및 시스템
ES2572811T3 (es) * 2004-09-09 2016-06-02 Yeda Research And Development Co., Ltd. Mezclas de polipéptidos, composiciones que las contienen y procedimientos para obtener los mismos, y usos de los mismos
US7097776B2 (en) * 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US20060093658A1 (en) * 2004-10-26 2006-05-04 Gayatri Sathyan Apparatus and method for transdermal delivery of desmopressin
CN100339081C (zh) 2004-11-10 2007-09-26 范敏华 一种氯雷他定口腔崩解片剂的制备方法
US7180274B2 (en) * 2004-12-10 2007-02-20 Aimtron Technology Corp. Switching voltage regulator operating without a discontinuous mode
TW200719886A (en) 2005-04-22 2007-06-01 Wyeth Corp Dihydrobenzofuran derivatives and uses thereof
WO2006116158A1 (en) 2005-04-22 2006-11-02 Wyeth Benzodioxane and benzodioxolane derivatives and uses thereof
CN101175740A (zh) 2005-04-22 2008-05-07 惠氏公司 二氢苯并呋喃衍生物和其用途
JP2008538573A (ja) 2005-04-22 2008-10-30 ワイス ベンゾフラニルアルカナミン誘導体およびその５−ｈｔ２ｃアゴニストとしての使用
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
PE20061297A1 (es) 2005-04-22 2006-12-24 Wyeth Corp Compuestos derivados de cromano y cromeno moduladores del receptor de serotonina 5-ht2c
EP1874292A2 (en) 2005-04-24 2008-01-09 Wyeth Methods for modulating bladder function
US20080213461A1 (en) 2005-06-17 2008-09-04 Georgia Tech Research Corporation Coated Microstructures and Methods of Manufacture Thereof
EP1904158B1 (en) 2005-06-24 2013-07-24 3M Innovative Properties Company Collapsible patch with microneedle array
WO2007083323A2 (en) 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
CA2584456C (en) 2006-03-02 2008-07-22 Ferring International Center S.A. Composition comprising desmopressin
US8101114B2 (en) 2006-05-01 2012-01-24 Georgia Tech Research Corporation Particle based molding
US8399410B2 (en) 2007-08-06 2013-03-19 Allergan, Inc. Methods and devices for desmopressin drug delivery
NO2296686T3 (zh) * 2008-05-21 2014-07-12

Also Published As

Publication number Publication date
SI2712622T1 (sl) 2016-10-28
PL2296686T5 (pl) 2018-06-29
LUC00015I2 (zh) 2017-06-19
TR201819189T4 (tr) 2019-01-21
EP3225249B1 (en) 2018-11-07
HUE041370T2 (hu) 2019-05-28
DK3225249T3 (en) 2019-02-25
JP6258424B2 (ja) 2018-01-10
HUE039013T4 (hu) 2019-08-28
HRP20191854T1 (hr) 2019-12-27
EP3085381A1 (en) 2016-10-26
SI3085381T1 (en) 2018-06-29
ES2462465T3 (es) 2014-05-22
CA2724653A1 (en) 2009-11-26
DK2712622T3 (en) 2016-09-12
LT3225250T (lt) 2019-11-11
JP2016196514A (ja) 2016-11-24
PL3085381T3 (pl) 2018-09-28
HRP20161066T1 (hr) 2016-10-21
EP3225250A1 (en) 2017-10-04
LUC00015I1 (zh) 2017-04-19
JP6506821B2 (ja) 2019-04-24
LTPA2017001I1 (lt) 2017-02-10
HRP20190114T1 (hr) 2019-03-08
HUE039013T2 (hu) 2018-12-28
JP5767103B2 (ja) 2015-08-19
DK2296686T4 (en) 2018-01-02
JP2019123739A (ja) 2019-07-25
DK3225250T3 (da) 2019-11-04
LTC2712622I2 (lt) 2020-02-10
NO2019021I1 (no) 2019-04-30
JP2015120761A (ja) 2015-07-02
PL3225249T3 (pl) 2019-05-31
DK2296686T3 (da) 2014-05-12
HUS1900024I1 (hu) 2019-05-28
JP6836618B2 (ja) 2021-03-03
EP3085381B1 (en) 2018-04-18
EP2296686A1 (en) 2011-03-23
PT3225250T (pt) 2019-10-15
JP2018035198A (ja) 2018-03-08
ES2710454T3 (es) 2019-04-25
DK3085381T3 (en) 2018-05-28
PT2712622T (pt) 2016-10-13
EP3225250B1 (en) 2019-08-21
HUE046050T2 (hu) 2020-01-28
JP2011520980A (ja) 2011-07-21
LT3085381T (lt) 2018-06-11
PT3085381T (pt) 2018-05-18
PT2296686E (pt) 2014-05-23
PL2296686T3 (pl) 2014-07-31
US20090291880A1 (en) 2009-11-26
LT3225249T (lt) 2019-01-10
US20180250357A1 (en) 2018-09-06
EP2712622A1 (en) 2014-04-02
US9974826B2 (en) 2018-05-22
ES2756706T3 (es) 2020-04-27
EP3225249A1 (en) 2017-10-04
HUE030409T2 (en) 2017-05-29
EP2712622B1 (en) 2016-07-13
EP2296686B1 (en) 2014-02-12
ES2596435T3 (es) 2017-01-09
PL3225250T3 (pl) 2020-02-28
ES2462465T5 (es) 2018-02-28
LT2712622T (lt) 2016-09-26
SI3225250T1 (sl) 2019-11-29
PT3225249T (pt) 2019-01-17
NO3085381T3 (zh) 2018-09-15
ES2677548T3 (es) 2018-08-03
WO2009143356A1 (en) 2009-11-26
PL2712622T3 (pl) 2017-01-31
JP6001121B2 (ja) 2016-10-05
SI3225249T1 (sl) 2019-02-28
TR201807224T4 (tr) 2018-06-21
HRP20180774T1 (hr) 2018-08-10
EP2296686B2 (en) 2017-11-01

Similar Documents

Publication Publication Date Title
BR112016019572A2 (zh)
BRPI0909040A2 (zh)
BRPI0917573A2 (zh)
BRPI0908549B8 (zh)
BRPI0918697A2 (zh)
BRPI0917525A2 (zh)
BRPI0920750A2 (zh)
BRPI0919470A2 (zh)
BRPI0922455A2 (zh)
BRPI0917618A8 (zh)
BRPI0907698A2 (zh)
BRPI0923734A2 (zh)
BRPI0912727A2 (zh)
BRPI0908285A2 (zh)
BRPI0910485A2 (zh)
BRPI0922669A2 (zh)
BRPI0914750A2 (zh)
BRPI0908120A2 (zh)
BRPI0912462A2 (zh)
BRPI0915616A2 (zh)
BRPI0904541A8 (zh)
BRPI0919811A2 (zh)
BRPI0920914A2 (zh)
BRPI0922550A2 (zh)
BRPI0916284A2 (zh)